NCT01121289 - A Trial Investigating NN1218 in Subjects With Type 1 Diabetes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

July 31, 2010

Study Completion Date

July 31, 2010

Conditions

DiabetesDiabetes Mellitus, Type 1

Interventions

DRUG

NN1218

0.2 U/kg body weight injected subcutaneously (under the skin)

DRUG

insulin aspart

0.2 U/kg body weight injected subcutaneously (under the skin)

DRUG

NN1218

0.2 U/kg body weight injected subcutaneously (under the skin)

DRUG

NN1218

0.4 U/kg body weight injected subcutaneously (under the skin)

DRUG

NN1218

0.2 U/kg body weight injected subcutaneously (under the skin)

DRUG

NN1218

0.2 U/kg body weight injected subcutaneously (under the skin)

Trial Locations (1)

Neuss